Mortality and risk factors of vaccinated and unvaccinated frail patients with COVID-19 treated with anti-SARS-CoV-2 monoclonal antibodies: A real-world study.
Nevola R, Feola G, Ruocco R, Russo A, Villani A, Fusco R, De Pascalis S, Core MD, Cirigliano G, Pisaturo M, Loffredo G, Rinaldi L, Marrone A, Starace M, Sposito PL, Cozzolino D, Salvatore T, Lettieri M, Marfella R, Sasso FC, Coppola N, Adinolfi LE.
Nevola R, et al. Among authors: marrone a.
Int J Infect Dis. 2023 Jun;131:155-161. doi: 10.1016/j.ijid.2023.03.030. Epub 2023 Mar 20.
Int J Infect Dis. 2023.
PMID: 36944382
Free PMC article.